BOEHRINGER INGELHEIM SELLS PHARMATON TO U.S. COMPANY

German drugmaker Boehringer Ingelheim and IdeaSphere, based in the U.S., have announced the sale of Boehringer Ingelheim´s Natural Healthcare company and Pharmaton company to IdeaSphere. Financial terms of the transaction were not disclosed.

"IdeaSphere … will be the ideal partner to further develop Pharmaton, while Boehringer Ingelheim will continue to strengthen its Consumer Healthcare business by further building up the flagship and international core brands, e.g. Dulcolax, Buscopan or Antistax", said Dr Alessandro Banchi, chairman of Boehringer Ingelheim's board of directors.

IdeaSphere will take over all Pharmaton business and brands. Both companies agreed on a cooperation to toll-manufacture specific products. To facilitate the transfer of the Pharmaton business, Boehringer Ingelheim will continue to distribute the Pharmaton products for a transitional period.